Cost-Benefit Analysis

"Cost-Benefit Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.

Descriptor ID	D003362
MeSH Number(s)	N03.219.151.125
Concept/Terms	Cost-Benefit Analysis Cost-Benefit Analysis Analyses, Cost-Benefit Analysis, Cost-Benefit Cost-Benefit Analyses Cost Benefit Analysis Analyses, Cost Benefit Analysis, Cost Benefit Cost Benefit Analyses Cost Effectiveness Cost Effectiveness Effectiveness, Cost Cost-Benefit Data Cost-Benefit Data Cost Benefit Data Data, Cost-Benefit Cost-Utility Analysis Cost-Utility Analysis Analyses, Cost-Utility Analysis, Cost-Utility Cost Utility Analysis Cost-Utility Analyses Economic Evaluation Economic Evaluation Economic Evaluations Evaluation, Economic Evaluations, Economic Marginal Analysis Marginal Analysis Analyses, Marginal Analysis, Marginal Marginal Analyses Cost Benefit Cost Benefit Costs and Benefits Benefits and Costs Cost-Effectiveness Analysis Cost-Effectiveness Analysis Analysis, Cost-Effectiveness Cost Effectiveness Analysis

Below are MeSH descriptors whose meaning is more general than "Cost-Benefit Analysis".

Health Care [N]
Health Care Economics and Organizations [N03]
Economics [N03.219]
Costs and Cost Analysis [N03.219.151]
Cost-Benefit Analysis [N03.219.151.125]

Below are MeSH descriptors whose meaning is related to "Cost-Benefit Analysis".

Below are MeSH descriptors whose meaning is more specific than "Cost-Benefit Analysis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cost-Benefit Analysis" by people in this website by year, and whether "Cost-Benefit Analysis" was a major or minor topic of these publications.

Bar chart showing 108 publications over 29 distinct years, with a maximum of 9 publications in 2005

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1991	0	2	2
1993	0	2	2
1994	0	1	1
1995	0	3	3
1996	0	3	3
1997	0	4	4
1998	0	3	3
1999	0	2	2
2000	0	5	5
2001	0	1	1
2002	0	1	1
2003	1	3	4
2004	1	1	2
2005	0	9	9
2006	0	5	5
2007	0	3	3
2008	2	5	7
2009	0	4	4
2010	1	5	6
2011	0	1	1
2012	0	4	4
2013	1	3	4
2014	2	4	6
2015	0	5	5
2016	0	4	4
2017	0	1	1
2018	1	3	4
2019	2	4	6
2020	0	6	6

Below are the most recent publications written about "Cost-Benefit Analysis" by people in Profiles.

Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Farewell V, Stoll T, Buyon J, Clarke AE. Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach. Arthritis Care Res (Hoboken). 2020 12; 72(12):1800-1808.

View in: PubMed
Reuben DB, Gill TM, Stevens A, Williamson J, Volpi E, Lichtenstein M, Jennings LA, Tan Z, Evertson L, Bass D, Weitzman L, Carnie M, Wilson N, Araujo K, Charpentier P, Meng C, Greene EJ, Dziura J, Liu J, Unger E, Yang M, Currie K, Lenoir KM, Green AS, Abraham S, Vernon A, Samper-Ternent R, Raji M, Hirst RM, Galloway R, Finney GR, Ladd I, Rahm AK, Borek P, Peduzzi P. D-CARE: The Dementia Care Study: Design of a Pragmatic Trial of the Effectiveness and Cost Effectiveness of Health System-Based Versus Community-Based Dementia Care Versus Usual Dementia Care. J Am Geriatr Soc. 2020 11; 68(11):2492-2499.

View in: PubMed
Muston D, Hettle R, Monberg M, McLaurin KK, Gao W, Swallow E, Zhang S, Kalemaj I, Signorovitch J, Moore K. Cost-effectiveness of olaparib as a maintenance treatment for women with newly diagnosed advanced ovarian cancer and BRCA1/2 mutations in the United States. Gynecol Oncol. 2020 11; 159(2):491-497.

View in: PubMed
Williams M, Zantow E, Turrentine M. Response to Letter. Obstet Gynecol. 2020 08; 136(2):429-430.

View in: PubMed
Williams M, Zantow E, Turrentine M. Cost Effectiveness of Latest Recommendations for Group B Streptococci Screening in the United States. Obstet Gynecol. 2020 04; 135(4):789-798.

View in: PubMed
Mundey P, Slemaker A, Dopp AR, Beasley LO, Silovsky JF. Qualitative Analysis of Administrator, Provider, and Stakeholder Views on the Costs and Benefits of a Treatment for Problematic Sexual Behavior of Youth. Adm Policy Ment Health. 2020 01; 47(1):126-137.

View in: PubMed
Trevillion K, Ryan EG, Pickles A, Heslin M, Byford S, Nath S, Bick D, Milgrom J, Mycroft R, Domoney J, Pariante C, Hunter MS, Howard LM. An exploratory parallel-group randomised controlled trial of antenatal Guided Self-Help (plus usual care) versus usual care alone for pregnant women with depression: DAWN trial. J Affect Disord. 2020 01 15; 261:187-197.

View in: PubMed
Blair AB, Sorber R, Rozich NS, Burkhart RA. A Qualitative Review of Neoadjuvant Chemotherapy in Resectable Pancreatic Adenocarcinoma. Pancreas. 2019 09; 48(8):973-984.

View in: PubMed
Dopp AR, Mundey P, Silovsky JF, Hunter M, Slemaker A. Economic value of community-based services for problematic sexual behaviors in youth: A mixed-method cost-effectiveness analysis. Child Abuse Negl. 2020 07; 105:104043.

View in: PubMed
Jennings LA, Laffan AM, Schlissel AC, Colligan E, Tan Z, Wenger NS, Reuben DB. Health Care Utilization and Cost Outcomes of a Comprehensive Dementia Care Program for Medicare Beneficiaries. JAMA Intern Med. 2019 02 01; 179(2):161-166.

View in: PubMed

People

Explore

Similar Concepts

Top Journals